Director’s Report Dr C.P. Wild International Agency for Research on Cancer Lyon, France

International Agency for Research on Cancer
Lyon, France
Director’s Report
Dr C.P. Wild

100 days - First impressions
• Relevance of the Agency’s mission
•International
•Prevention
• Coordination
• Dedication of staff
• Need for organizational change

IARC Day
• Professor Harold zur Hausen, German Cancer
Research Centre
• Professor Nubia Muñoz, National Cancer
Institute, Colombia, formerly of IARC
Identification of human papillomavirus (HPV) as a
necessary cause of cervical cancer and the
development of a dual strategy of vaccination and
screening to reduce cancer burden
Integration of laboratory and epidemiology in
cancer prevention

Scientific organization
• Cluster structure
• Poor fit for some Groups; lack of identity
• Unclear leadership roles
•Section structure
• Consistent with major research activities
• Provide clear leadership and line management
• Support inter-disciplinary working

New IARC organizational structure
14 April 2009
IARC Scientific Council
Chairperson Vice-Chairperson
Dr H. Comber Dr E. Rivedal
IARC Governing Council
Chairperson Vice-Chairperson
Dr L.E. Hanssen (Norway) Dr P. Puska (Finland)
Director-General, WHO
Dr M. Chan
Director, IARC
(DIR)
Dr C.P. Wild
Group
Communi-
cations
(COM)
Dr N. Gaudin
Group
Education
and Training
(ETR)
TBA
Group
Scientific
Coordination
Office
(SCO)
Mr M. Pasterk
Group
The Gambia
Hepatitis
Intervention
Study (GHIS)
TBA
Section of
Cancer
Information
(CIN)
Dr M.-P. Curado
(Acting)
Section of
IARC
Monographs
(IMO)
Dr V. Cogliano
Section of
Mechanisms of
Carcinogenesis
(MCA)
Dr P. Hainaut
Section of
Molecular
Pathology
(MPA)
Dr H. Ohgaki
Section of
Infections
(INF)
Dr S. Franceschi
Section of
Environment
(ENV)
Dr P. Boffetta
Section of
Nutrition and
Metabolism
(NME)
Dr S. Franceschi
(Acting)
Section of
Genetics
(GEN)
Dr P. Brennan
Section of
Biomarkers
(BMA)
TBA
Section of
Early Detection
and Prevention
(EDP)
Dr R. Sankar-
anarayanan
Division of
Administration
and Finance
(DAF)
Mr P. Knoche
(Acting)
Group
Biostatistics
(BST)
Dr G. Byrnes
Group
Epigenetics
(EGE)
Dr Z. Herceg
Group
Infections and
Cancer Biology
(ICB)
Dr M. Tommasino
Group
Lifestyle
and Cancer
(LCA)
Dr P. Boffetta
Group
Dietary
Exposure
Assessment
(DEX)
Dr N. Slimani
Group
Genetic Cancer
Susceptibility
(GCS)
Dr S. Tavtigian
Group
Prevention
(PRE)
Dr P. Autier
Support service
Administrative
Services Office
(ASO)
Mr G. Guillerminet
Group
Data
Analysis and
Interpretation
(DEA)
Dr H.R. Shin
Group
Molecular
Carcinogenesis
(MOC)
Dr P. Hainaut
Group
Infections
and Cancer
Epidemiology
(ICE)
Dr S. Franceschi
Group
Radiation
(RAD)
Dr A. Kesminiene
Group
Genetic
Epidemiology
(GEP)
Dr P. Brennan
Group
Quality
Assurance
(QAS)
Dr L. von Karsa
Support service
Budget and
Finance Office
(BFO)
Mr P. Knoche
Group
Descriptive
Epidemiology
Production
(DEP)
Dr M.-P. Curado
Group
Screening
(SCR)
Dr R. Sankar-
anarayanan
Support service
Human
Resources
Office
(HRO)
Ms D. D’Amico
Support service
IARC Grants
Office
(IGO)
Dr O. Kelm
TBA:
to be appointed
Support service
Information
Technology
Services
(ITS)
Mr M. Smans
/mg